Magna have some shares to sell into any possible rise or dribble out at 20% profit on a continual basis. Good ol' spiral debt financing
QBL having drama with crop yield estimates, pricing , company structure and now merging assets as complicated structure no one could follow.
Structure of AEB is also complicated and constant advice they must be having to get to unwind it will be expensive and they have commitments in so many different directions . Management time absorbed makes ou wonder if they can really advance their "business" inbetween fighting fires.
Much of the finance is conditional, has lien over assets all with specific hurdles so AEB need to be very careful on how they go about things or have issues with financiers.
Talk of IPO etc need to be put in perspective of who would be the face and management of the IPO as you can't involve people with "baggage" as it will discount the interest and value significantly. Lot of talk and big dreams but odds of good execution in a timely manner are not high IMO. Market is getting wiser to MM and just how many companies are riding the wave while also understanding the lead times to actually having true trials and demand. Survival of the fittest and most robust companies with possibly big pharma backing in later years after all the fluff and wind has gone away.
AEB Price at posting:
2.0¢ Sentiment: None Disclosure: Not Held
